Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Resource Center: Depression

By Will Boggs, MD NEW YORK (Reuters Health) – In higher-risk patients with depression who respond to cognitive therapy, continuation-phase cognitive therapy and fluoxetine were equally effective at preventing a relapse in a randomized,...
By Kate Kelland LONDON (Reuters)- As Susan sits chatting to a nurse in a London clinic, a light tapping sound by her head signals that parts of her brain are being zapped by thousands of tiny electromagnetic pulses from a machine plugged into the...
(Reuters) – Generic drugmaker Teva Pharmaceutical Industries Ltd said it will stop development of a depression treatment after a late-stage trial failed to show the drug was more effective than placebo. The study was the third late-stage study that...